Mother Files Zyprexa Lawsuit Over Son's Diabetes
- September 14, 2006
A Louisiana woman has filed a lawsuit against Eli Lilly and Co., alleging that the company's drug Zyprexa caused her son to develop diabetes after only three months of use.
In addition to diabetes, Catherine Harrison claimed that her son suffered extreme pain, including severe stomach and bowel problems, as a result of taking Zyprexa. According to the complaint, her son will have lifelong medical bills.
The suit also alleges that Lilly failed to provide adequate labeling of the drug to warn of the potential risk of severe adverse side effects such as diabetes. Lilly added a heightened warning to Zyprexa's label in 2004 to include the risk of hyperglycemia and diabetes. The boy began using the drug in 2003.
Zyprexa is an anti-psychotic widely prescribed to treat bipolar disorder and schizophrenia. The Food and Drug Administration approved the drug in 1996 but has since determined that it carries a risk of elevated blood glucose.
Harrison filed the lawsuit earlier this week in the U.S. District Court in Baton Rouge. She is seeking unspecified damages on behalf of her son.
Injured by Zyprexa? Please contact us today to learn more about recovering damages for your losses.
Homepage • Lawsuit • Alternatives • Heart Attack • Injuries • Warning • Withdrawal • Risk • Diabetes • Side Effects • Reports • Information • Zyprexa and Women • Resources • Safety • News • Lawsuit Evaluation • Site Map
Whether
or not Zyprexa and similar atypical antipsychotic drugs are linked to diabetes
is a question that will be answered in the Zyprexa lawsuits that have been
filed. Patients have reported deadly instances of Zyprexa side effects. There
are 288 reported cases of Zyprexa diabetes cases, including 23 deaths.
Zyprexa maker Eli Lilly has enjoyed large success with Zyprexa, with the drug
currently the world’s top selling schizophrenia medication. The Zyprexa
side effects causing Zyprexa lawsuits may begin slowing the company’s
current financial success. For more information on